BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 33075648)

  • 1. Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel.
    Lecluse AL; Kuck-Koot VC; van Weelden H; Sigurdsson V; Russel IM; Frank J; Pasmans SG
    Eur J Pediatr; 2008 Jun; 167(6):703-6. PubMed ID: 17710435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria.
    Parker CJ; Desnick RJ; Bissel MD; Bloomer JR; Singal A; Gouya L; Puy H; Anderson KE; Balwani M; Phillips JD
    Mol Genet Metab; 2019 Nov; 128(3):309-313. PubMed ID: 31395332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements.
    Raef HS; Rebeiz L; Leaf RK; Hughes O; Jiang P; ElSeht A; Anderson KE; Wheeden K; Kochevar I; Elmariah SB; Dickey AK
    JAMA Dermatol; 2023 Feb; 159(2):204-208. PubMed ID: 36630131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iron supplements in individuals with erythropoietic protoporphyria.
    Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
    Photodiagnosis Photodyn Ther; 2024 May; 47():104211. PubMed ID: 38734198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational pilot study of multi-wavelength wearable light dosimetry for erythropoietic protoporphyria.
    Dickey AK; Berkovich J; Leaf RK; Jiang PY; Lopez-Galmiche G; Rebeiz L; Wheeden K; Kochevar I; Savage W; Zhao S; Campisi E; Heo SY; Trueb J; LaRochelle EPM; Rogers J; Banks A; Chang JK
    Int J Dermatol; 2024 Apr; ():. PubMed ID: 38602089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria.
    Mathias SD; Burke L; Colwell HH; Mensing G; Savage W; Naik H
    J Patient Rep Outcomes; 2023 Nov; 7(1):119. PubMed ID: 37982964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of erythropoietic protoporphyria with cholestatic liver disease: A case report.
    Poli A; Frieri C; Lefebvre T; Delforge J; Mirmiran A; Talbi N; Moulouel B; Six M; Paradis V; Parquet N; Puy H; Schmitt C; Aslangul E; de Fontbrune FS; Gouya L
    Mol Genet Metab Rep; 2023 Dec; 37():101018. PubMed ID: 38053924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver disease in erythropoietic protoporphyria: insights and implications for management.
    Anstey AV; Hift RJ
    Postgrad Med J; 2007 Dec; 83(986):739-48. PubMed ID: 18057171
    [No Abstract]   [Full Text] [Related]  

  • 9. A Mysterious Abdominal Pain.
    Zeng Q; Wu D; Tang H
    Gastroenterology; 2024 Jan; 166(1):27-30. PubMed ID: 37579823
    [No Abstract]   [Full Text] [Related]  

  • 10. Afamelanotide in protoporphyria and other skin diseases: a review.
    Polańska A; Wegner J; Nutbohm P; Staubach P; Żaba R; Dańczak-Pazdrowska A; Jenerowicz D
    Postepy Dermatol Alergol; 2024 Apr; 41(2):149-154. PubMed ID: 38784937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics.
    Hussain Z; Qi Q; Zhu J; Anderson KE; Ma X
    Pharmacol Ther; 2023 Aug; 248():108487. PubMed ID: 37392940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
    Leaf RK; Dickey AK
    Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective observational pilot study of quantitative light dosimetry in erythropoietic protoporphyria.
    Dickey AK; Rebeiz L; Raef H; Leaf RK; Elmariah S; Naik H; Anderson K; Conley J; Iyasere C; Zhao S; Birkenfeld JS; Arroyo-Gallego T; Wheeden K; Ducamp S; Christiani DC; Fleming MD; Kochevar I
    J Am Acad Dermatol; 2023 May; 88(5):1148-1151. PubMed ID: 36436693
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.
    Genovese G; Maronese CA; Moltrasio C; Piccinno R; Marletta DA; De Luca G; Graziadei G; Granata F; Di Pierro E; Cappellini MD; Marzano AV
    Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):141-149. PubMed ID: 34420239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming.
    Heerfordt IM; Heydenreich J; Philipsen PA; Lerche CM; Wulf HC
    J Photochem Photobiol B; 2020 Dec; 213():112054. PubMed ID: 33075648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria.
    Heerfordt IM; Wulf HC
    Br J Dermatol; 2016 Dec; 175(6):1284-1289. PubMed ID: 27603594
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.